Deeks SG - Search Results

1

Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF. SenGupta D, et al. Among authors: deeks sg. J Virol. 2011 Jul;85(14):6977-85. doi: 10.1128/JVI.00179-11. Epub 2011 Apr 27. J Virol. 2011. PMID: 21525339 Free PMC article.

2

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Hellerstein M, et al. Nat Med. 1999 Jan;5(1):83-9. doi: 10.1038/4772. Nat Med. 1999. PMID: 9883844

3

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

4

Factors influencing T-cell turnover in HIV-1-seropositive patients.

McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. McCune JM, et al. J Clin Invest. 2000 Mar;105(5):R1-8. doi: 10.1172/JCI8647. J Clin Invest. 2000. PMID: 10712441 Free PMC article.

5

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.

Deeks SG, Barbour JD, Martin JN, Swanson MS, Grant RM. Deeks SG, et al. J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334. J Infect Dis. 2000. PMID: 10720517

6

Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient.

Deeks SG, Martin JN. Deeks SG, et al. AIDS. 2001 Jan 5;15(1):117-9. doi: 10.1097/00002030-200101050-00017. AIDS. 2001. PMID: 11192853 No abstract available.

7

Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.

Deeks SG, Barbour JD, Grant RM, Martin JN. Deeks SG, et al. AIDS. 2002 Jan 25;16(2):201-7. doi: 10.1097/00002030-200201250-00009. AIDS. 2002. PMID: 11807304

8

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy.

Deeks SG, Hoh R, Grant RM, Wrin T, Barbour JD, Narvaez A, Cesar D, Abe K, Hanley MB, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK. Deeks SG, et al. J Infect Dis. 2002 Feb 1;185(3):315-23. doi: 10.1086/338467. Epub 2002 Jan 17. J Infect Dis. 2002. PMID: 11807713

9

A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

Deeks SG, Wagner B, Anton PA, Mitsuyasu RT, Scadden DT, Huang C, Macken C, Richman DD, Christopherson C, June CH, Lazar R, Broad DF, Jalali S, Hege KM. Deeks SG, et al. Mol Ther. 2002 Jun;5(6):788-97. doi: 10.1006/mthe.2002.0611. Mol Ther. 2002. PMID: 12027564 Free article. Clinical Trial.

10

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults.

Barbour JD, Wrin T, Grant RM, Martin JN, Segal MR, Petropoulos CJ, Deeks SG. Barbour JD, et al. Among authors: deeks sg. J Virol. 2002 Nov;76(21):11104-12. doi: 10.1128/jvi.76.21.11104-11112.2002. J Virol. 2002. PMID: 12368352 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

695 results

Search Page

Filters